Left cardiac sympathetic denervation in long QT syndrome: Analysis of therapeutic nonresponders

J. Martijn Bos, Katy M. Bos, Jonathan N. Johnson, Christopher Moir, Michael J. Ackerman

Research output: Contribution to journalArticlepeer-review

63 Scopus citations


Background-Long QT syndrome (LQTS) is a potentially lethal but highly treatable cardiac channelopathy. Treatment options include pharmacotherapy, device therapy, and left cardiac sympathetic denervation (LCSD). Here, we sought to determine the characteristics of LQTS patients who have had ≥1 LQTS-related breakthrough cardiac event (BCE) after LCSD. Methods and Results-We performed retrospective chart review for 52 consecutive patients (24 males; mean age at diagnosis, 10.0±10 years; mean QTc, 528±74 ms) with LQTS who underwent LCSD between 2005 and 2010 (mean age at LCSD, 14.1±10 years) and have been followed up for 3.6±1.3 years. A BCE was defined as either (1) an appropriate ventricular fibrillation-terminating implantable cardioverter defibrillator shock or (2) arrhythmogenic syncope, seizures, or aborted cardiac arrest after LCSD. Thirty-three patients (61%) had LCSD as primary prevention because of either high-risk assessment or β-blocker intolerance. So far, 12 of 52 (23%) patients (7 males) have experienced ≥1 BCE post LCSD. The clinical phenotype of patients with BCEs was significantly more severe than patients without a BCE. No BCEs were seen in patients undergoing LCSD for β-blocker intolerance (0/12 versus 17/40; P<0.001). Conclusions-Although a marked reduction in number of cardiac events is usually seen after LCSD, ≈50% of high-risk LQTS patients have experienced ≥1 post-LCSD breakthrough. Therefore, LCSD must not be viewed as curative or as an alternative in implantable cardioverter defibrillator for high-risk patients. Prophylactic LCSD may provide another option to counter a suboptimal quality of life resulting from medication-related side effects.

Original languageEnglish (US)
Pages (from-to)705-711
Number of pages7
JournalCirculation: Arrhythmia and Electrophysiology
Issue number4
StatePublished - Aug 2013


  • Arrhythmias
  • Cardiac
  • Death sudden, cardiac
  • Left cardiac sympathetic denervation
  • Long QT syndrome
  • Syncope

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'Left cardiac sympathetic denervation in long QT syndrome: Analysis of therapeutic nonresponders'. Together they form a unique fingerprint.

Cite this